Life Science News

RSS

Scientists identify new virus in deepest part of the ocean

The Mariana Trench, the deepest place on Earth, plunges nearly 11,000 meters at its lowest point on the floor of the Pacific Ocean. Life persists in the deep and cold darkness, and "wherever there's life, you can bet there are regulators at work," said marine virologist Min Wang, Ph.D, at the Ocean University of China, in Qingdao. "Viruses, in this case."

20 Sep 2023

Cell Signaling Technology and Beyond Benign collaborate to advance green chemistry education

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced a partnership with global green chemistry education nonprofit Beyond Benign.

From Cell Signaling Technology 20 Sep 2023

CST and Leica Biosystems partner to enable companion diagnostics for personalized medicine

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, is partnered with Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging, to support the development of companion diagnostics (CDx) assays using the extensive portfolio of best-in-class antibodies from CST validated for immunohistochemistry (IHC).

From Cell Signaling Technology 20 Sep 2023

Yogurt may help eliminate garlic odors

It turns out yogurt may have a previously unknown benefit: eliminating garlic odors.

19 Sep 2023

Real-time live tissue sensitivity assay could be used as a personalized strategy for pancreatic cancer

A new research paper was published in Oncotarget's Volume 14 on September 15, 2023, entitled, "Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma."

19 Sep 2023

DeepMind develops new tool to predict pathogenicity of missense variants

DeepMind is releasing AlphaMissense, a tool researchers can use to learn more about the effects that missense mutations – which make up the majority of "variants of uncertain significance" – have on disease.

19 Sep 2023

LabGenius & Sanofi partnership yields positive results from AI antibody discovery platform

Today, LabGenius, a pioneer in the use of AI and machine learning for antibody discovery, releases new data from its antibody discovery platform following a multi-year collaboration with Sanofi.

From LabGenius 19 Sep 2023

Waters launches new walk-up solutions that further simplify the analysis of biologic drug product and cell culture media

Waters Corporation announced new bioprocess walk-up solutions designed to further simplify biologic sample prep and analysis.

From Waters Corporation 19 Sep 2023

Analyzing longitudinal genomic surveillance of carriage intensive care unit

Hospital staff spend a significant amount of time working to protect patients from acquiring infections while they are being cared for in the hospital.

19 Sep 2023

Nanoparticle gene delivery system shows promise for treating ARDS

Discovery from the lab of Youyang Zhao, PhD, from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago offers promising treatment approaches for acute respiratory distress syndrome (ARDS) in the elderly that can be caused by severe COVID-19, pneumonia, flu or sepsis. Currently there are no pharmacological or cell-based treatments for ARDS.

19 Sep 2023

Ongoing gene therapy trials have driven increased use of ALS genetic testing, finds study

Researchers at The Ohio State University Wexner Medical Center and College of Medicine led the creation of evidence-based consensus guidelines for genetic testing and counseling for patients with amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that affects the cells in the brain and spine.

19 Sep 2023

Researchers identify new blood marker for dopamine system damage

The marker in question is called DOPA decarboxylase (DCC). In the current study, DCC was found to be elevated in individuals with Parkinson's disease as well as in people with other diseases that result in dopamine deficiency in the brain. However, the marker was normal in other brain diseases such as Alzheimer's disease. The researchers even noticed that DCC was elevated in individuals with Parkinson's many years before they developed any symptoms.

19 Sep 2023

Adaptive platform trial shows promise for finding new glioblastoma therapies

An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute in collaboration with 10 major brain tumor centers around the country and designed to find new potential treatments for glioblastoma has reported initial results in the Journal of Clinical Oncology. While none of the three therapeutics tested so far improved overall survival of patients, this adaptive platform trial, the first of its kind in neuro-oncology, has the potential to rapidly and efficiently identify therapies that benefit patients.

19 Sep 2023

New CAR T cell therapy approach minimizes severe side effects

In recent years, cancer researchers have hailed the arrival of chimeric antigen receptor T cell (CAR T) therapy, which has delivered promising results, transforming the fight against various forms of cancer. The process involves modifying patients' T-cells to target cancer cells, resulting in remarkable success rates for previously intractable forms of cancer.

19 Sep 2023

New research offers insight about the reason mitochondrial DNA is maternally inherited

New research provides insight about the bedrock scientific principle that mitochondrial DNA - the distinct genetic code embedded in the organelle that serves as the powerplant of every cell in the body - is exclusively passed down by the mother.

19 Sep 2023

Meridian Bioscience announces FDA clearance for innovative Curian® Shiga Toxin Assay

Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials.

From Meridian Bioscience, Inc. 18 Sep 2023

Meridian Bioscience continues expansion of H. pylori diagnostic testing solutions with FDA clearance of premier HpSA flex

Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials.

From Meridian Bioscience, Inc. 18 Sep 2023

Single-cell screening of cerebral organoids to identify developmental defects in autism

Researchers develop CRISPR-human organoids-single-cell RNA sequencing system to identify developmental brain defects in autism.

18 Sep 2023

MGI partners with National Cancer Centre Singapore to undergo comprehensive genomic profiling of Asian-Prevalent cancers

MGI Tech Singapore Pte, Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, recently entered a research partnership with National Cancer Centre Singapore ("NCCS") to facilitate comprehensive, multi-dimensional genomic profiling of Asian-prevalent cancers using MGI's core DNBSEQ™ technology.

From MGI 18 Sep 2023

MGI and Bio-Medical Science sign MOU to deliver cutting-edge sequencing platforms and reagents to South Korea

MGI, a company committed to building core tools and technology to lead life science, today announced MOU with Bio-Medical Science Co., Ltd. ("BMS") to expand genomics solutions in South Korea by leveraging MGI's cutting-edge technology.

From MGI 18 Sep 2023

Life Science News

Scientists identify new virus in deepest part of the ocean

Cell Signaling Technology and Beyond Benign collaborate to advance green chemistry education

CST and Leica Biosystems partner to enable companion diagnostics for personalized medicine

Yogurt may help eliminate garlic odors

Real-time live tissue sensitivity assay could be used as a personalized strategy for pancreatic cancer

DeepMind develops new tool to predict pathogenicity of missense variants

LabGenius & Sanofi partnership yields positive results from AI antibody discovery platform

Waters launches new walk-up solutions that further simplify the analysis of biologic drug product and cell culture media

Analyzing longitudinal genomic surveillance of carriage intensive care unit

Nanoparticle gene delivery system shows promise for treating ARDS

Ongoing gene therapy trials have driven increased use of ALS genetic testing, finds study

Researchers identify new blood marker for dopamine system damage

Adaptive platform trial shows promise for finding new glioblastoma therapies

New CAR T cell therapy approach minimizes severe side effects

New research offers insight about the reason mitochondrial DNA is maternally inherited

Meridian Bioscience announces FDA clearance for innovative Curian® Shiga Toxin Assay

Meridian Bioscience continues expansion of H. pylori diagnostic testing solutions with FDA clearance of premier HpSA flex

Single-cell screening of cerebral organoids to identify developmental defects in autism

MGI partners with National Cancer Centre Singapore to undergo comprehensive genomic profiling of Asian-Prevalent cancers

MGI and Bio-Medical Science sign MOU to deliver cutting-edge sequencing platforms and reagents to South Korea

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Latest Life Science News